Hepatitis B Drug Pipeline Research Report 2024
April 18, 2024 11:44 ET
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report outlays comprehensive insights of...
Chronic Hepatitis B Market Forecast to 2032: Significant Growth Expected with USD 1,500 Million in US 7MM and Emerging Therapies Uptake
December 11, 2023 08:38 ET
|
Research and Markets
Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The "Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Global...
H2 2020 Hepatitis B Pipeline Review - Therapeutics Development, Drug Profiles and Product Development Milestones
December 23, 2020 02:28 ET
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Hepatitis B - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. The pipeline guide provides comprehensive...
Global Hepatitis B Market Spotlight 2020: GlaxoSmithKline Leads Industry Sponsors with by Far the Highest Overall Number of Clinical Trials
October 05, 2020 06:59 ET
|
Research and Markets
Dublin, Oct. 05, 2020 (GLOBE NEWSWIRE) -- The "Market Spotlight: Hepatitis B" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Hepatitis B...